The ; subunit is a component of the Fcy receptor of natural killer cells (FcyRIll or CD16), as well as the multimeric T-cell receptor/CD3 complex, and is required for assembly of both native receptors. The role of the C subunit in human FcyRIIIA assembly differs from its role in T-cell receptor/CD3 complex assembly. The transmembrane domain of the FcyRIIIA a subunit forms noncovalent interactions with the comparable domain of the ; subunit and is sufficient for surface expression of the FcyRIIA complex. In the absence of these interactions, sequences in the transmembrane domain of the FcyRMA a subunit signal its degradation. present in the transmembrane domain of the human ; subunit, is important for assembly with the FcyRIIIA a subunit. Substitution of this leucine with an isoleucine, as found in the mouse {subunit, significantly reduces this interaction. In contrast, the mouse and human ; subunits interact with the pentameric T-cell receptor/CD3 complex, resulting in surface expression of this receptor.
receptor/CD3 complex assembly. The transmembrane domain of the FcyRIIIA a subunit forms noncovalent interactions with the comparable domain of the ; subunit and is sufficient for surface expression of the FcyRIIA complex. In the absence of these interactions, sequences in the transmembrane domain of the FcyRMA a subunit signal its degradation. Leu-46, present in the transmembrane domain of the human ; subunit, is important for assembly with the FcyRIIIA a subunit. Substitution of this leucine with an isoleucine, as found in the mouse {subunit, significantly reduces this interaction. In contrast, the mouse and human ; subunits interact with the pentameric T-cell receptor/CD3 complex, resulting in surface expression of this receptor.
Receptors for IgG immune complexes, the Fcy receptors (FcyRs), are a heterogeneous family of membrane receptors on cells of the immune system that mediate a diverse array of cellular responses to antibody-antigen complexes (for review, see refs. [1] [2] [3] . FcyRIIIA, the FcyR on natural killer (NK) cells, is an oligomeric complex that mediates antibodydependant cellular cytotoxicity and NK-cell activation upon cross-linking with immune complexes (4) . These responses are mediated through the stimulation of inositol phospholipid hydrolysis and increased intracellular calcium (5) . FcyRIIIA is composed of at least three polypeptide chains: a ligandrecognition subunit, termed FcyRIIIA-a, and the associated y and ; chains (6) (7) (8) (9) (10) (11) . FcyRIIIA-a from human NK cells has been shown to exist in three molecular forms in association with Y2, {2, or y; chains (11) . These associated chains are required for surface expression of the a subunit (8) (9) (10) and are presumed to be involved in signaling pathways, triggered by cross-linking of the a subunit by ligand. The y and ; subunits were initially identified as necessary components of other receptors. The y chain is a component ofthe multimeric high-affinity Fce receptor for IgE (FceRI) (12) , and the ; chain is a component of the T-cell receptor (TCR)/CD3 complex (13) . The 'y and chains are required for surface receptor expression of FceRI and TCR/CD3, respectively, and demonstrate significant sequence homology (14, 15) . In TCR/CD3 assembly, the ' chain plays a unique role in targeting pentameric complexes (TCR a and P chains/CD3 'y, 8 , and E chains) to the cell surface and sparing the incompletely assembled complex from degradation (16, 17) . In this report, we describe results relevant to the mechanism by which the ; chain mediates FcyRIIIA assembly and the sequence requirements for these assembly processes.
MATERIALS AND METHODS
Cell Culture and Antibodies. COS-7 cells were cultured in modified Eagle's medium containing 10% (vol/vol) fetal calf serum. The peptide synthesized from the cytoplasmic domain of FcyRIIIA-a was used to raise the polyclonal antibody against the a chain. The y and ; chains were made by overexpressing their respective cDNA sequences in the bacterial system described by Studier and Moffatt (18) . The complete coding sequences were cloned into the BamHI site of pET3xb to create a fusion protein with the T7 gene 10 protein and used to transform Escherichia coli BL21(DE3). The fusion protein was induced with isopropyl f3-Dthiogalactoside and the overexpressed molecules were purified by SDS/PAGE. The eluted proteins were used to raise rabbit polyclonal antibodies.
DNA Constructions and DNA Transfection. Point mutants and hybrid molecules were constructed by PCR amplification or oligonucleotide-directed mutagenesis on single-stranded templates and cloned into the pCEXV-3 expression vector (19) . DNA was transfected into COS-7 cells by using calcium phosphate precipitation in the presence of 100 ,M chloroquine followed by a 20% (vol/vol) glycerol shock.
Immunoprecipitation and Fluorescence-Activated Cell Sorter (FACS) Analysis. Transfected cells were permeabilized with digitonin (10 ,g/ml) for 10 min on ice and iodinated with 1251 by 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril (Iodo-Gen) (6) . Cells were solubilized in lysis buffer containing 1% digitonin and 0.12% Triton X-100 (11) . Cell lysates were sequentially incubated for 2 hr at 4°C with antibodies and then with protein A-Sepharose. Digestion with endoglycosaminidase H (endo H) was performed by incubating immunoprecipitated proteins for 16 hr at 37°C with 5 x 10 3 units of endo H in 0.1 M sodium phosphate (pH 6.1) containing 0.1% Triton X-100, 0.03% SDS, and 20 mM EDTA. Sepharose-bound immune complexes were eluted into sample buffer. FACS analysis was carried out using the antiFcyIII monoclonal antibody (mAb) 3G8 or a nonbinding irrelevant mAb, B77, as described (10) .
In Vitro Analysis. The cDNA sequences of a, y, and chains were cloned into pGEM-3Z and transcribed in vitro. These RNAs were translated in an in vitro translation reaction mixture containing 1 ,ug of the RNA in a nuclease-treated reticulocyte lysate (Promega) (11), demonstrating that the interactions of a, y, and {chains can be reconstituted by their coexpression in COS cells and do not appear to require other NK-cell-specific proteins.
The mechanism by which y and ; subunits facilitate surface expression of multimeric complexes containing a subunit was determined by characterizing the intracellular fate of FcyRIIIA-a in the presence or absence of y and ; chains. Pulse-chase labeling of the COS cells transfected with Fc'yRIIIA-a alone, shown in Fig. 2B , indicates that the a chain is degraded over the course of 6 hr. Endo H treatment of pulse-chase-labeled immunoprecipitates demonstrates that the a chain does not acquire resistance to this enzyme, implying the inability of the a subunit to reach the Golgi system. In contrast, pulse-chase studies of COS cells transfected with y and ; chain cDNAs demonstrate that these molecules are stable (data not shown) and are capable of reaching the cell surface in the absence of a chain ( Fig. 1 A  and (6h). acquired resistance to endo H ( Fig. 2 C and D) . Fc-yRIIIB, normally expressed as a glycosyl phosphatidylinositol anchored protein in neutrophils (6) , is rapidly converted to an endo H-resistant molecule, indicating that its processing and movement to the Golgi are more rapid than FcyRIIIA ( Fig.  2A) . These results indicate that y and ; chains can interfere with the degradation of the a chain and allow these complexes to reach the Golgi system. It is likely that this occurs through noncovalent interactions between the a chain and the y or ; chain in the endoplasmic reticulum (ER) as shown in Fig. 3 . mRNAs for lckyRIIIA-a and 'y and ; chains, synthesized in vitro, were translated in a cell-free system in the presence of microsomes and immonoprecipitated with antibodies directed against each chain. These microsome preparations contain only ER membranes and are free of con-RNA a he ma he me h FcyRIIIA-a contains a signal that results in its degradation. We have shown (10) that deletion of the cytoplasmic domain of FcyRIIIA-a did not affect its degradation. A series of chimeric molecules were constructed with FcyRIIIA-a and y and ; chains to identify this degradation signal (Fig. 4A) . When the transmembrane and cytoplasmic domains of the a chain were replaced with the comparable domains of the y or ; chain, stable accumulation and cell surface expression of these chimeric molecules were observed (ahZ or ay, respectively). The same result was obtained when the mouse FcyRII transmembrane and cytoplasmic domains were substituted for mouse Fc'yRIII-a sequences (R. L. Weinshank, and J.V.R., unpublished results). These experiments suggest that the 21-amino acid transmembrane sequence of the a chain contains a signal that determines its degradation. The interaction ofFcyRIIIA-a with y or {chain in the ER protects it from degradation and probably masks this signal. y and ; chains may also provide the appropriate signal for directing the a-chain-containing complex from the ER to the Golgi. The sites of interaction between a and ; chains could be mapped as a consequence of our previous observation that coexpression of the human ; chain with a chain in COS cells results in efficient surface expression, whereas the mouse ; chain is 5-7% as efficient in its ability to function in the assembly of either human or mouse FcyRIIIA-a (10). Chimeric molecules constructed between human and mouse g chains were tested for their ability to enhance FcyRIIIA-a surface expression (Fig. 4A) Fig. 3 . When mouse ; mRNA was translated in a cell-free extract supplemented with microsomal membranes and a chain, a complex between these chains could not be detected, in contrast to the situation when human ; chain was used. y and ; chains exist as disultide-linked homo-and heterodimers (7, 11, 16, 20, 23) in all the receptor complexes in which they have been found. To determine if disulfide-linked dimerization of these subunits is essential for their ability to assemble with FcyRIIIA-a, we mutated the cysteine at position 32 to a serine in the human ; chain and constructed the homologous cysteine mutation (Cys-25 -* Ser) in the 'y chain. These molecules were expressed on the cell surface (27, 28) protein interactions, occurring in the lipid bilayer. Both the FcyRIIIA-a and the TCRa have charged amino acids in their transmembrane domain. These residues appear to play a critical role in the assembly of these subunits in the ER. Mutation of the Asp-222 residue in the transmembrane domain of FcyRIIIA-a decreases its susceptibility to degradation and reduces its ability to interact with y and human g chains (10) . Similar observations have been made for TCRa assembly with CD38 (26) . In contrast to the role of the transmembrane domains in assembly, truncation of the cytoplasmic domains of either the a or the human ; chain has a less dramatic effect on this process (10) . In addition to the role of charged residues interrupting the hydrophobic stretch of amino acids spanning the bilayer, a surprising degree of specificity was observed in the hydrophobic interactions that occur in this domain. The Leu -* Ile substitution in the transmembrane domain of ; chain resulted in a significant decrease in its ability to interact with Fc'yRIIIA-a. Thus the results presented herein indicate that a high degree of specificity is contained within the transmembrane domains of oligomeric receptor complexes. The role of this domain is considerably more dynamic and complex than previously thought. Rather than functioning as a passive hydrophobic nonspecific anchor through the lipid bilayer, this domain contains specific recognition signals for degradation, receptor assembly, and subcellular targeting.
